Catherine Droitcourt
Overview
Explore the profile of Catherine Droitcourt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pineau C, Adamski H, Nivot-Adamiak S, Desquiret-Dumas V, Bonneau P, Boussemart L, et al.
Eur J Dermatol
. 2025 Feb;
34(6):672-674.
PMID: 39912476
No abstract available.
2.
Droitcourt C, Kerbrat S, Raby M, Laurent C, Travers D, Balusson F, et al.
Dermatology
. 2024 Dec;
1-11.
PMID: 39709951
Introduction: Oral isotretinoin is the only effective treatment for severe acne without an alternative. Isotretinoin has been linked to the occurrence of acute psychiatric disorders outside suicidal behaviors. There are...
3.
Beyrouti A, Deuze J, Fontas E, Foureau A, Barbarot S, Aubert H, et al.
J Allergy Clin Immunol Pract
. 2024 Dec;
13(2):353-360.
PMID: 39672377
Background: Patients with atopic dermatitis (AD) may discontinue dupilumab owing to dupilumab-induced ocular adverse events (DOAEs) or dupilumab-induced facial redness (DFR). Objective: To evaluate DOAE and DFR outcomes after switching...
4.
Courtois A, Allaume P, Raby M, Pastoret C, Droitcourt C, Le Naoures C, et al.
Am J Dermatopathol
. 2024 Dec;
47(2):95-104.
PMID: 39660957
Mycosis fungoides (MF) and Sezary syndrome (SS) are common entities among primary cutaneous lymphomas. Large cell transformation is challenging for diagnosis and therapy. Molecular mechanisms by which these lymphomas undergo...
5.
Dupuis J, Tauber M, Mahe E, Jachiet M, Soria A, Tetart F, et al.
J Eur Acad Dermatol Venereol
. 2024 Jul;
39(2):e174-e178.
PMID: 39082796
No abstract available.
6.
Barbarot S, Aubert H, Vibet M, Leray M, Foureau A, Elan F, et al.
Br J Dermatol
. 2024 Jun;
191(2):177-186.
PMID: 38863109
Background: Therapeutic patient education (TPE) is recommended for children with atopic dermatitis (AD), but no consensus has been reached on the optimal tailoring of delivery. While repeated multidisciplinary group education...
7.
Le Tallec E, Bourg C, Bouzille G, Belhomme N, Le Pabic E, Guillot S, et al.
Rheumatology (Oxford)
. 2023 Oct;
63(8):2178-2188.
PMID: 37831905
Objectives: SLE is a systemic autoimmune disease characterized by heterogeneous manifestations and severity, with frequent lung involvement. Among pulmonary function tests, the measure of the diffusing capacity of the lungs...
8.
Litovsky J, Hacard F, Tetart F, Boccon-Gibod I, Soria A, Staumont-Salle D, et al.
J Allergy Clin Immunol Pract
. 2023 Aug;
11(12):3752-3762.e2.
PMID: 37652349
Background: Omalizumab (OMA) dramatically improves disease control and quality of life in patients with chronic urticaria (CU). Objective: We aimed to evaluate the discontinuation patterns of OMA and their determinants...
9.
Orly J, Bisdorff A, Fraissenon A, Joly A, Boulouis G, Guibaud L, et al.
Eur J Radiol
. 2023 Jul;
165:110962.
PMID: 37423018
Purpose: Intramuscular capillary-type hemangiomas (ICTHs) are rare entities, belonging to the group of intramuscular "hemangiomas." The diagnosis remains challenging. We aimed to assess the diagnostic criteria, treatments and outcomes of...
10.
Ertus C, Scailteux L, Lescoat A, Berthe P, Auffret V, Dupuy A, et al.
Br J Dermatol
. 2023 Jul;
189(4):368-380.
PMID: 37410552
Background: On the basis of safety data for patients with inflammatory rheumatism or inflammatory bowel disease, treatment with Janus kinase (JAK) inhibitors (JAKi) has been linked to the occurrence of...